These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9935269

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of evodiamine on gastrointestinal motility in male rats.
    Wu CL, Hung CR, Chang FY, Lin LC, Pau KY, Wang PS.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):169-76. PubMed ID: 12464363
    [Abstract] [Full Text] [Related]

  • 24. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway.
    Glatzle J, Darcel N, Rechs AJ, Kalogeris TJ, Tso P, Raybould HE.
    Am J Physiol Regul Integr Comp Physiol; 2004 Aug 20; 287(2):R354-9. PubMed ID: 15117731
    [Abstract] [Full Text] [Related]

  • 25. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
    Mönnikes H, Lauer G, Arnold R.
    Brain Res; 1997 Oct 03; 770(1-2):277-88. PubMed ID: 9372230
    [Abstract] [Full Text] [Related]

  • 26. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents.
    Schwartz GJ, McHugh PR, Moran TH.
    Am J Physiol; 1993 Oct 03; 265(4 Pt 2):R872-6. PubMed ID: 8238459
    [Abstract] [Full Text] [Related]

  • 27. Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakamura H, Kihara Y, Tashiro M, Kanagawa K, Shirohara H, Yamamoto M, Yoshikawa H, Fukumitsu K, Hirohata Y, Otsuki M.
    J Gastroenterol; 1998 Oct 03; 33(5):702-9. PubMed ID: 9773935
    [Abstract] [Full Text] [Related]

  • 28. Cholecystokinin and prostaglandins inhibit responses of vagal afferent activity to systemic administration of nicotine in anesthetized rats.
    Kurosawa M, Taniguchi T, Yoneda M.
    Neurosci Lett; 2004 May 27; 362(3):213-5. PubMed ID: 15158017
    [Abstract] [Full Text] [Related]

  • 29. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene.
    Miyasaka K, Kanai S, Ohta M, Kawanami T, Kono A, Funakoshi A.
    Neurosci Lett; 1994 Oct 24; 180(2):143-6. PubMed ID: 7700567
    [Abstract] [Full Text] [Related]

  • 30. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat.
    Kawabata S, Kanayama S, Shinomura Y, Miyazaki Y, Imamura I, Moriwaki K, Wada H, Tarui S.
    Regul Pept; 1991 Jul 23; 35(1):1-10. PubMed ID: 1924892
    [Abstract] [Full Text] [Related]

  • 31. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat.
    Richards W, Hillsley K, Eastwood C, Grundy D.
    J Physiol; 1996 Dec 01; 497 ( Pt 2)(Pt 2):473-81. PubMed ID: 8961188
    [Abstract] [Full Text] [Related]

  • 32. Gastric emptying in OLETF rats not expressing CCK-A receptor gene.
    Shoji E, Okumura T, Onodera S, Takahashi N, Harada K, Kohgo Y.
    Dig Dis Sci; 1997 May 01; 42(5):915-9. PubMed ID: 9149042
    [Abstract] [Full Text] [Related]

  • 33. Startle and sensorimotor gating in rats lacking CCK-A receptors.
    Feifel D, Priebe K, Shilling PD.
    Neuropsychopharmacology; 2001 Jun 01; 24(6):663-70. PubMed ID: 11331146
    [Abstract] [Full Text] [Related]

  • 34. OLETF (Otsuka Long-Evans Tokushima Fatty) rats that lack the CCK 1 (A) receptor develop less behavioral sensitization to repeated cocaine treatment than wild type LETO (Long Evans Tokushima Otsuka) rats.
    Beinfeld MC, Connolly K, Pierce RC.
    Peptides; 2001 Aug 01; 22(8):1285-90. PubMed ID: 11457522
    [Abstract] [Full Text] [Related]

  • 35. Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones.
    Li Y, Wu XY, Owyang C.
    J Physiol; 2004 Sep 01; 559(Pt 2):651-62. PubMed ID: 15235095
    [Abstract] [Full Text] [Related]

  • 36. Integration of vagal afferent responses to gastric loads and cholecystokinin in rats.
    Schwartz GJ, McHugh PR, Moran TH.
    Am J Physiol; 1991 Jul 01; 261(1 Pt 2):R64-9. PubMed ID: 1858957
    [Abstract] [Full Text] [Related]

  • 37. Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors.
    Covasa M, Ritter RC.
    Peptides; 2001 Aug 01; 22(8):1339-48. PubMed ID: 11457530
    [Abstract] [Full Text] [Related]

  • 38. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
    Tachibana I, Akiyama T, Kanagawa K, Shiohara H, Furumi K, Watanabe N, Otsuki M.
    Am J Physiol; 1996 Apr 01; 270(4 Pt 1):G730-7. PubMed ID: 8928805
    [Abstract] [Full Text] [Related]

  • 39. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach.
    Burdyga G, de Lartigue G, Raybould HE, Morris R, Dimaline R, Varro A, Thompson DG, Dockray GJ.
    J Neurosci; 2008 Nov 05; 28(45):11583-92. PubMed ID: 18987194
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats.
    Kurosawa M, Uvnäs-Moberg K, Miyasaka K, Lundeberg T.
    J Auton Nerv Syst; 1997 Jan 12; 62(1-2):72-8. PubMed ID: 9021652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.